bronchial asthma and other respiratoroy diseaseas, sharing some clinical manifestation.
Conditions
Interventions
None listed
Sponsors
Kyorin University Shool of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Participants are those who were already diagnosed or suspected with asthma, those who chronically complain respiratory symptoms such as cough, those who were allergic with no symptoms, and those who might be other diseases with respiratopry symptoms including COPD, lung cancer and disseminated lung diseases, as well as healthy individuals. In this process, internationa primary care airway group (IPAG) quesstionairres and other questionnairres will be utilized. They should be twenty years old or over and give informed consent on the basis that the study is approved by each local ethics committee.
Exclusion criteria
Exclusion criteria: Those whe are dianosed with pulmonary infection, severe cardiologic, hepatic and/or renal issues, are to be excluded. This decision is to be made according by physicians in charge.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (1) Air pollution (2) general assessment of asthma and airway inflammation (3) genetic polymorphism Association between them is investigated. | — |
Secondary
| Measure | Time frame |
|---|---|
| In addition to the above mentioned intems, the following items is investigated, indcluidng (1) mediators in EBC (2) mediators in blood (3) oxidative stress of EBC and blood (4) inflammatory biomarkers | — |
Countries
Japan
Contacts
Public ContactKazuki Tabata
Kyorin University Ethical Committee
Outcome results
None listed